Wockhardt which has received US FDA warning letters on four of its plants is now facing an issue with Ireland's drug regulator.The Irish drug regulator did not recommend the renewal of good manufacturing practices (GMP) certificate of Wockhardt's Shendra ... Business Standard, 2 weeks ago
USFDA issues warning letter to Megafine Pharma for Vapi plant - Business Standard, 2 weeks ago
One Indian pharmaceutical firm’s nighttime document-shredding and potential manufacturing lapses at two others since December are reigniting concerns that, despite recent efforts, the country’s generic-drug industry still has a way to go to gain the trust ...The Financial Chronicle, 2 months ago
BS ReporterHyderabad, 22 March: The US Food and Drug Administration(US FDA) has invoked one more clause with regard to the import alert issued to Unit-2 of Hyderabad-based Divis Laboratories Limited, this time charging the company with 'refusal for ...Business Standard, 6 days ago
BS ReporterHyderabad, 9 MarchIn a continued set back to drug major Dr Reddy's Laboratories Limited's remediation efforts, its oncology formulations facility at Duvvada in Visakhapatnam of Andhra Pradesh has received Form 483 with 13 observations from the US ...Business Standard, 2 weeks ago
Posted by Equitymaster After opening the day flat, Indian share markets have gone on to trade marginally below the dotted line. Sectoral indices are trading on a mixed note with stocks in the realty sector and oil & gas sector witnessing maximum buying ...Equitymaster.com, 3 weeks ago Sensex Opens Flat; IT Stocks Lead the Losses Equitymaster.com, 3 weeks ago Sensex Trades on a Positive Note; Power Stocks Gain Equitymaster.com, 2 months ago
Suit alleges fraud by hiding significant deficiencies in CGMP regulations enforced by US health regulator. Seoul-based biotech company Mezzion Pharma has filed a suit against Dr Reddy’s Laboratories in a US court. It has alleged the Hyderabad-based supplier had committed fraud by hiding significant deficiencies in the Current Good Manufacturing Practice, or CGMP, regulations enforced by the US health regulator. In the suit, filed in the state of New Jersey, Mezzion seeks to “recover ...Rediff.com, 2 months ago
on your WebpageAdd Widget >Get your members hooked!